How much did Anacalypsis Therapeutics raise?

Anacalypsis Therapeutics raised €300K at Pre-Seed, announced 21 September 2026.

Who founded Anacalypsis Therapeutics?

Alexia V. Polissidis is Co-founder & CEO of Anacalypsis Therapeutics.

What does Anacalypsis Therapeutics do?

Anacalypsis Therapeutics operates in HealthTech and is based in Greece.

FundedStartupsDaily / HealthTech / Anacalypsis Therapeutics

Anacalypsis Therapeutics raises €300K

Anacalypsis Therapeutics announced a Pre-Seed round of €300K on 21 September 2026. The company operates in HealthTech and is based in Greece. It was founded by Alexia V. Polissidis, Co-founder & CEO. Announced yesterday.

Raised

€300K

Stage

Pre-Seed

Industry

HealthTech

Country

Greece

Founder

Alexia V. Polissidis

Co-founder & CEO, Anacalypsis Therapeutics

LinkedIn profile anacalypsistherapeutics.com

Outreach angles

-Alexia V. Polissidis co-founded Anacalypsis Therapeutics in 2019 with Chief Scientific Officer Hardy J. Rideout.
-Polissidis holds a PhD and built her academic career in neuroscience research before co-founding the company.
-The round is the first investment by Greece's Metavallon VC Brain Gain Fund into a domestic drug-discovery biotech.